CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Prometheus Laboratories Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Prometheus Laboratories Inc.
9410 Carroll Park Drive
Phone: (858) 824-0895p:858 824-0895 San Diego, CA  92121  United States

This is a Subsidiary, click here for the Parent Company

Business Summary
Prometheus Laboratories Inc. develops pharmaceutical and diagnostic products. The Company focuses on the detection, diagnosis and treatment of disorders within the fields of gastroenterology and oncology. Its strategy includes the marketing and delivery of pharmaceutical products by proprietary diagnostic testing services. The Company develops therapeutics; Proleukin (aldesleukin), LOTRONEX (alosetron hydrochloride), Helidac (bismuth subsalicylate/metronidazole/tetracycline/ hydrochloride), Imuran (azathioprine) and Ridaura (auranofin). And also develops diagnostics; Crohn's Prognostic, IBD Serology, Celiac, Thiopurine Monitoring and TPMT Testing. The Company was founded in 1995 and is headquartered in San Diego, California.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201012/31/2010YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Timothy R.Sear 74 11/1/2004 9/1/2004
President, Chief Executive Officer, Director Joseph M.Limber 59 8/26/2008 12/1/2003
Chief Financial Officer, Senior Vice President Mark E.Spring 8/26/2008 8/26/2008
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Prometheus Biosciences, Inc.
Prometheus Holdings, Inc.
Prometheus Laboratories Inc.
Prometheus RxDx Corp

General Information
Number of Employees: 478 (As of 2/1/2011)
Outstanding Shares: 25,676,663 (As of 12/31/2010)
Shareholders: 212
Stock Exchange: NASD
Federal Tax Id: 330685754


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023